Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02655874
What this trial is testing

Tropical Influenza Control Strategies for the Elderly

Who this might be right for
Influenza, Human
Tan Tock Seng Hospital 200
Post-approval studies (Phase 4)UnknownNCT03756246
What this trial is testing

Influenza Vaccine as a Novel Experimental Model of the Behavioral Immune Response in Depression

Who this might be right for
DepressionHealthy
University of Texas at Austin 75
Post-approval studies (Phase 4)Study completedNCT00161122
What this trial is testing

Prevention of Respiratory Infections and MAnagement Among Children (PRIMAKid)

Who this might be right for
Recurrent Upper and Lower Respiratory Tract Infections (RTIs)
UMC Utrecht 660
Post-approval studies (Phase 4)Study completedNCT03020537
What this trial is testing

B-cell Immunity to Influenza (SLVP017)- Year 5, 2013

Who this might be right for
Influenza
Stanford University 8
Large-scale testing (Phase 3)Looking for participantsNCT07626437
What this trial is testing

Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg Chlorpheniramine Maleate in Improving Symptoms of the Common Cold and Flu in Adults

Who this might be right for
Common Cold/FluNasal CongestionNasal Obstruction
Brainfarma Industria Química e Farmacêutica S/A 620
Early research (Phase 1)Study completedNCT00382980
What this trial is testing

Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 308
Post-approval studies (Phase 4)Study completedNCT00649922
What this trial is testing

Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Abbott 226
Testing effectiveness (Phase 2)Study completedNCT00391391
What this trial is testing

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children

Who this might be right for
Orthomyxoviridae InfectionInfluenzaMyxovirus Infection
Sanofi 520
Early research (Phase 1)Study completedNCT02251288
What this trial is testing

A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine

Who this might be right for
Avian InfluenzaImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 62
Not applicableStudy completedNCT05690373
What this trial is testing

Probiotics and Influenza Vaccination Response

Who this might be right for
Vaccine Response
The Archer-Daniels-Midland Company 100
Large-scale testing (Phase 3)Study completedNCT02256488
What this trial is testing

Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects

Who this might be right for
Prophylaxis: Influenza
Novartis Vaccines 1,561
Not applicableStudy completedNCT01431183
What this trial is testing

Seasonal Influenza Vaccination Reminders for Children With High-risk Conditions

Who this might be right for
Seasonal Influenza Vaccination
University of Michigan 3,618
Testing effectiveness (Phase 2)Study completedNCT01949090
What this trial is testing

Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older

Who this might be right for
Influenza
GlaxoSmithKline 363
Not applicableStudy completedNCT04794829
What this trial is testing

Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination

Who this might be right for
InfluenzaCOVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 75
Testing effectiveness (Phase 2)Study completedNCT01359150
What this trial is testing

Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or Placebo

Who this might be right for
Rheumatoid Arthritis
Pfizer 223
Not applicableStudy completedNCT03748160
What this trial is testing

Herd Immunity and Influenza Vaccine Uptake

Who this might be right for
Influenza, Human
Finnish Institute for Health and Welfare 48,125
Testing effectiveness (Phase 2)Study completedNCT00976820
What this trial is testing

Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 323
Post-approval studies (Phase 4)Study completedNCT03022396
What this trial is testing

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010

Who this might be right for
Influenza
Stanford University 82
Not applicableStudy completedNCT03056924
What this trial is testing

Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab

Who this might be right for
Inflammatory Bowel Diseases
Boston Medical Center 173
Testing effectiveness (Phase 2)Study completedNCT01682369
What this trial is testing

ADITEC FLU STUDY: Understanding the Genetic Basis for Immune Responses

Who this might be right for
Influenza
University of Oxford 90
Next Page